- Home
- ATRA vs DXR Comparison
ATRA vs DXR Comparison
Compare ATRA & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- DXR
- Stock Information
- Founded
- ATRA 2012
- DXR 1970
- Country
- ATRA United States
- DXR United States
- Employees
- ATRA N/A
- DXR N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- DXR Medical/Dental Instruments
- Sector
- ATRA Health Care
- DXR Health Care
- Exchange
- ATRA Nasdaq
- DXR Nasdaq
- Market Cap
- ATRA 51.1M
- DXR 46.1M
- IPO Year
- ATRA 2014
- DXR N/A
- Fundamental
- Price
- ATRA $11.58
- DXR $10.14
- Analyst Decision
- ATRA Strong Buy
- DXR Strong Buy
- Analyst Count
- ATRA 4
- DXR 1
- Target Price
- ATRA $20.00
- DXR $25.00
- AVG Volume (30 Days)
- ATRA 57.7K
- DXR 3.2K
- Earning Date
- ATRA 08-11-2025
- DXR 01-01-0001
- Dividend Yield
- ATRA N/A
- DXR N/A
- EPS Growth
- ATRA N/A
- DXR 86.16
- EPS
- ATRA N/A
- DXR 0.11
- Revenue
- ATRA $199,732,000.00
- DXR $119,714.00
- Revenue This Year
- ATRA N/A
- DXR N/A
- Revenue Next Year
- ATRA N/A
- DXR N/A
- P/E Ratio
- ATRA N/A
- DXR $92.00
- Revenue Growth
- ATRA 475.53
- DXR N/A
- 52 Week Low
- ATRA $5.01
- DXR $6.55
- 52 Week High
- ATRA $18.71
- DXR $10.23
- Technical
- Relative Strength Index (RSI)
- ATRA 66.87
- DXR 65.31
- Support Level
- ATRA $8.53
- DXR $9.05
- Resistance Level
- ATRA $13.46
- DXR $9.90
- Average True Range (ATR)
- ATRA 0.96
- DXR 0.29
- MACD
- ATRA 0.28
- DXR 0.02
- Stochastic Oscillator
- ATRA 62.65
- DXR 100.00
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.